Muhammad Umair Mushtaq: Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation
Muhammad Umair Mushtaq, Associate Professor of Medicine at the University of Kansas Medical Center, shared a post on LinkedIn about a recent paper by him and colleagues published in Transplantation and Cellular Therapy:
Authors: Moazzam Shahzad, Qamar Iqbal, Muhammad Kashif Amin, Amir Kasaiean, Iman Menbari Oskouie, Sarmad Zaman Warraich, James Yu, Iqra Anwar, Michael Jaglal and Muhammad Umair Mushtaq.
“Shahzad M … Mushtaq MU. Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Aged 70 Years and Older: A Systematic Review and Meta-analysis. Transplantation and Cellular Therapy. 2025″
More posts featuring Muhammad Umair Mushtaq.
Muhammad Umair Mushtaq (Abu Mikael), M.D., is an Associate Professor of Medicine in Hematology/Oncology and Transplantation/Cellular Therapy at the University of Kansas Medical Center.
He is a clinical investigator and physician specializing in hematologic malignancies, bone marrow transplant, cellular therapy, immunotherapy, and global health. Dr. Mushtaq previously completed a Hematology and Oncology Fellowship at the University of Wisconsin-Madison.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023